Most Read Articles
Tristan Manalac, 01 Mar 2019
Poor diet quality appears to impair mental health, according to a new study.
05 Mar 2019
Obesity and allergic disease increase the risk of mental health problems in adolescents, a recent Korea study has found.
Tristan Manalac, 15 Mar 2019
Neither multinutrient supplementation nor food-related behavioural activation therapy appear to protect against major depressive disorder (MDD) episodes in overweight or obese adults with subsyndromal depressive symptoms, according to a recent study.
11 Apr 2019
Cannabis use disorder appears to exert a beneficial effect on the risk of disorders of gut–brain interaction and inflammatory bowel disease in patients with schizophrenia but not in population controls, a study has found. This finding raises the possibility of new targets for treatment and prevention of digestive organ disorders in schizophrenia.

Ginkgo biloba extract improves cognition and overall condition after ischaemic stroke

Christina Lau
23 Nov 2018
Dr Yanxin Zhao speaking at VasCog 2018

Use of a ginkgo biloba extract on top of standard preventive treatment is shown to improve cognitive function and overall condition after acute ischaemic stroke. 

In a multicentre pilot study, patients aged ≥50 years (n=201) who had an ischaemic stroke 7–14 days before baseline were randomized to receive standard treatment for prevention of stroke recurrence with or without EGb 761, a ginkgo biloba extract taken three times daily, for 24 weeks.

“Results showed significant improvements in cognitive function, mainly in memory, language, orientation and processing speed, in the EGb 761 vs standard treatment group, as assessed by Montreal Cognitive Assessment [MoCA] and Hopkins Verbal Learning Test [HVLT],” reported investigator Dr Yanxin Zhao of Fudan University, Shanghai, China, at VasCog 2018.

“Eighty percent of patients in the EGb 761 group had very much or much improved overall condition, compared with 20 percent of patients in the standard treatment group [p<0.05]. Neuropsychiatric symptoms and stroke-related symptoms were very mild at baseline, and improved slightly and to similar degrees in both groups,” he continued. “EGb 761 was safe and well tolerated in the study.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 01 Mar 2019
Poor diet quality appears to impair mental health, according to a new study.
05 Mar 2019
Obesity and allergic disease increase the risk of mental health problems in adolescents, a recent Korea study has found.
Tristan Manalac, 15 Mar 2019
Neither multinutrient supplementation nor food-related behavioural activation therapy appear to protect against major depressive disorder (MDD) episodes in overweight or obese adults with subsyndromal depressive symptoms, according to a recent study.
11 Apr 2019
Cannabis use disorder appears to exert a beneficial effect on the risk of disorders of gut–brain interaction and inflammatory bowel disease in patients with schizophrenia but not in population controls, a study has found. This finding raises the possibility of new targets for treatment and prevention of digestive organ disorders in schizophrenia.